LONDON: GSK’s new CEO Luke Miels said today that the drugmaker will aim to lift sales growth and speed up work on new medicines in its next phase of growth through a sharper focus on programmes that ...

Emma Walmsley has served as CEO of GlaxoSmithKline since 2017. From the Philadelphia Business Journal. GSK is making a change at the top. The London-based Big Pharma company, which has major ...

LONDON, June 9 (Reuters) - GSK (GSK.L), opens new tab has agreed to buy U.S.-listed cancer drug developer Nuvalent (NUVL.O), opens new tab for $10.6 billion in its largest deal in more than a decade, ...

GSK said today it now expects to start more than 20 late-stage studies in 2026, up from a previous target of 10 GSK has today launched a £1.9 billion cost-savings drive to help fund the British ...

GSK plans to take the TCE to Phase I clinical trials in multiple myeloma during 2027.

GSK is consolidating two of its influenza vaccine manufacturing sites into one, leaving hundreds of jobs at risk.  | GSK is ...

GSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid what a spokesperson said is ...

GSK plc (NYSE:GSK) is advancing its experimental seasonal influenza vaccine into late-stage development after encouraging mid ...

Sept 15 (Reuters) - GSK said on Tuesday it had agreed a deal worth up to $750 million to buy a trispecific T cell-engager (TCE), a drug designed to help T-cells target cancer, from China-based ...

LONDON, Feb 4 (Reuters) - GSK's new CEO Luke Miels said on Wednesday that the drugmaker will aim to lift sales growth and speed up work on new medicines in its next ‌phase of growth through a sharper ...